Álvaro Rodríguez-Lescure

16PUBLICATIONS
53CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 02, 2026
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.

|May 26, 2026
Sensitivity to Endocrine Therapy Index Predicts Benefit from Weekly Adjuvant Paclitaxel for Hormone Receptor-Positive Breast Cancer in the GEICAM/9906 Trial.

|Feb 24, 2026
Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM).

Sara López-Tarruella, Ángel Guerrero-Zotano, Silvia Antolín

|Jul 30, 2025
Revisiting Alma Ata: A Blueprint for Cancer Care.

Javier-David Benitez-Fuentes, Rodrigo Lastra Del Prado, Miguel Borregon-Rivilla

|Dec 05, 2024
Potential Negative Impacts of the CCI4EU Initiative on Spain.

Javier David Benitez Fuentes, Asia Ferrandez Arias, Miguel Borregon Rivilla

|Apr 05, 2024
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.

Álvaro Rodríguez-Lescure, Javier Gallego, Pilar Garcia-Alfonso

Pageof 3

Frequent Collaborators

5 joint publications

Javier-David Benitez-Fuentes

4 joint publications

Miguel Borregon Rivilla

2 joint publications

María Torrente

2 joint publications

Alicia de Luna Aguilar